Pharmaceutical policies in a crisis?: Challenges and solutions identified at the PPRI Conference

Sabine Vogler; Nina Zimmermann; Alessandra Ferrario; Veronika J Wirtz; Kees de Joncheere; Hanne Bak Pedersen; Guillaume Dedet; Valérie Paris; Aukje K Mantel-Teeuwisse; Zaheer-Ud-Din Babar; Scientific Programme Committee of the 2015 PPRI Conference

doi:10.1186/s40545-016-0056-8

Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference

Sabine Vogler, Nina Zimmermann, Alessandra Ferrario, Veronika J Wirtz, Kees de Joncheere, Hanne Bak Pedersen, Guillaume Dedet, Valérie Paris, Aukje K Mantel-Teeuwisse, Zaheer-Ud-Din Babar, Scientific Programme Committee of the 2015 PPRI Conference

Pharmacoepidemiology and Clinical Pharmacology

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

In October 2015, the third international Pharmaceutical Pricing and Reimbursement Information (PPRI) Conference was held in Vienna to foster discussion on challenges in pricing and reimbursement policies for medicines. The research presented highlighted that commonly used pharmaceutical pricing and reimbursement policies are not sufficiently effective to address current challenges. Conference participants called for fundamental reforms to ensure access to medicines, particularly to new and potentially more effective and/or safe medicines, while safeguarding the financial sustainability of health systems and working towards universal health coverage.

Original language	English
Article number	9
Number of pages	5
Journal	Journal of Pharmaceutical Policy and Practice
Volume	9
DOIs	https://doi.org/10.1186/s40545-016-0056-8
Publication status	Published - 2016

Keywords

Pricing
Reimbursement
Medicine prices
High-cost medicines
Biosimilars
Europe
Challenges
Debate
Cooperation

Access to Document

10.1186/s40545-016-0056-8

PharmaceuticalFinal published version, 382 KB

Cite this

Vogler, S., Zimmermann, N., Ferrario, A., Wirtz, V. J., de Joncheere, K., Pedersen, H. B., Dedet, G., Paris, V., Mantel-Teeuwisse, A. K., Babar, Z.-U.-D., & Scientific Programme Committee of the 2015 PPRI Conference (2016). Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference. Journal of Pharmaceutical Policy and Practice, 9, Article 9. https://doi.org/10.1186/s40545-016-0056-8

@article{8110974e3e39438ba552de7323d30f23,

title = "Pharmaceutical policies in a crisis?: Challenges and solutions identified at the PPRI Conference",

abstract = "In October 2015, the third international Pharmaceutical Pricing and Reimbursement Information (PPRI) Conference was held in Vienna to foster discussion on challenges in pricing and reimbursement policies for medicines. The research presented highlighted that commonly used pharmaceutical pricing and reimbursement policies are not sufficiently effective to address current challenges. Conference participants called for fundamental reforms to ensure access to medicines, particularly to new and potentially more effective and/or safe medicines, while safeguarding the financial sustainability of health systems and working towards universal health coverage.",

keywords = "Pricing, Reimbursement, Medicine prices, High-cost medicines, Biosimilars, Europe, Challenges, Debate, Cooperation",

author = "Sabine Vogler and Nina Zimmermann and Alessandra Ferrario and Wirtz, {Veronika J} and {de Joncheere}, Kees and Pedersen, {Hanne Bak} and Guillaume Dedet and Val{\'e}rie Paris and Mantel-Teeuwisse, {Aukje K} and Zaheer-Ud-Din Babar and {Scientific Programme Committee of the 2015 PPRI Conference}",

year = "2016",

doi = "10.1186/s40545-016-0056-8",

language = "English",

volume = "9",

journal = "Journal of Pharmaceutical Policy and Practice",

issn = "2052-3211",

publisher = "Taylor and Francis Ltd.",

}

Vogler, S, Zimmermann, N, Ferrario, A, Wirtz, VJ, de Joncheere, K, Pedersen, HB, Dedet, G, Paris, V, Mantel-Teeuwisse, AK, Babar, Z-U-D & Scientific Programme Committee of the 2015 PPRI Conference 2016, 'Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference', Journal of Pharmaceutical Policy and Practice, vol. 9, 9. https://doi.org/10.1186/s40545-016-0056-8

TY - JOUR

T1 - Pharmaceutical policies in a crisis?

T2 - Challenges and solutions identified at the PPRI Conference

AU - Vogler, Sabine

AU - Zimmermann, Nina

AU - Ferrario, Alessandra

AU - Wirtz, Veronika J

AU - de Joncheere, Kees

AU - Pedersen, Hanne Bak

AU - Dedet, Guillaume

AU - Paris, Valérie

AU - Mantel-Teeuwisse, Aukje K

AU - Babar, Zaheer-Ud-Din

AU - Scientific Programme Committee of the 2015 PPRI Conference

PY - 2016

Y1 - 2016

N2 - In October 2015, the third international Pharmaceutical Pricing and Reimbursement Information (PPRI) Conference was held in Vienna to foster discussion on challenges in pricing and reimbursement policies for medicines. The research presented highlighted that commonly used pharmaceutical pricing and reimbursement policies are not sufficiently effective to address current challenges. Conference participants called for fundamental reforms to ensure access to medicines, particularly to new and potentially more effective and/or safe medicines, while safeguarding the financial sustainability of health systems and working towards universal health coverage.

AB - In October 2015, the third international Pharmaceutical Pricing and Reimbursement Information (PPRI) Conference was held in Vienna to foster discussion on challenges in pricing and reimbursement policies for medicines. The research presented highlighted that commonly used pharmaceutical pricing and reimbursement policies are not sufficiently effective to address current challenges. Conference participants called for fundamental reforms to ensure access to medicines, particularly to new and potentially more effective and/or safe medicines, while safeguarding the financial sustainability of health systems and working towards universal health coverage.

KW - Pricing

KW - Reimbursement

KW - Medicine prices

KW - High-cost medicines

KW - Biosimilars

KW - Europe

KW - Challenges

KW - Debate

KW - Cooperation

U2 - 10.1186/s40545-016-0056-8

DO - 10.1186/s40545-016-0056-8

M3 - Article

C2 - 26981252

SN - 2052-3211

VL - 9

JO - Journal of Pharmaceutical Policy and Practice

JF - Journal of Pharmaceutical Policy and Practice

M1 - 9

ER -

Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference

Abstract

Keywords

Access to Document

Fingerprint

Cite this